|
Actually yes! It is probably true that the biometrics market will open-up in few months, as soon as the Y2K issue becomes history, as we enter the new millennium. I would assume that the bank which gave the credit line to MYT did its due diligence. Also, the products that MYT has now available for sale seem to work fine and are competitively priced. How good the sale and marketing people at MYT are, I do not know, but it would appear that the Chairman has excellent contacts. Probably MYT will not be # 1, but it should be able to gain few market share points. Moreover, I do not exclude a takeover by a bigger company. We all know, for instance, that MYT previous CEO is now at Canon, and he still is a Member of the Board at MYT. Other possibilities exist of course. Unfortunately I see MYT weak in P.R. and the money issue (Company excuse) is not relevant; I can not understand why an aggressive P.R. strategy is not in place at MYT. Has any one of those who post here attended the Annual Meeting on June 17? I live in Florida and could not be there also because on June 15 I lost my "significant other" of ten years to pancreatic cancer! I would encourage MYT senior management to be more talkative, but this is something that they do not want to understand, as well. I would like to read other opinions on the present situation at MYT and outlook for the near future. Am I the only faithful guy around? |
